Dear Colleagues:

Please complete the below needs assessment questionnaire to help us apply for educational grants for programs that cardiologists really want and need. Please indicate whether information about the following topics would be of interest to you.

Norman Lepor, MD


ARE YOU INTERESTED IN:
  Very
interested		 Somewhat
interested		 Not
interested
1 How the results of the JUPITER trial, which showed cardiovascular event reduction with rosuvastatin in patients with no cardiovascular disease and elevated hs-CRP, may affect primary prevention
2 The use of hs-CRP as an independent marker of cardiovascular risk and as part of a routine cardiovascular risk assessment
3 The ability of cardiovascular imaging (carotid IMT, coronary calcium, CT coronary angiography, MR) to enhance cardiovascular risk assessment
4 Ways to increase patient compliance with prescribed medical therapy
5 The cardiovascular effects of diabetes treatments
6 The goals of glycemic therapy for patients with diabetes
7 The role of hyperglycemia in macrovascular events and the impact of treatment on event reduction
8 How prevention of microvascular events (proteinuria, retinopathy) in patients with diabetes impacts macrovascular events (myocardial infarction, heart failure, stroke)
9 Recent clinical trial data on the usefulness of thiazolidinediones (TZDs) in treating patients with diabetes